Strs Ohio Organon & Co. Transaction History

Strs Ohio

$24.7 Billion
Q1 2024

A detailed history of Strs Ohio transactions in Organon & Co. stock. As of the latest transaction made, Strs Ohio holds 101 shares of OGN stock, worth $2,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares

101

Previous 101 -0.0%

Holding current value

$2,032

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$10.95 - $17.32 $870,765 - $1.38 Million	-79,522 Reduced 99.87%	101 $1,000
Q3 2023 Oct 26, 2023	BUY	$16.59 - $23.77 $1.32 Million - $1.89 Million	79,522 Added 78734.65%	79,623 $1.38 Million
Q2 2023 Jul 31, 2023	SELL	$19.27 - $24.63 $1.14 Million - $1.46 Million	-59,299 Reduced 99.83%	101 $2,000
Q1 2023 Aug 02, 2023	BUY	$21.42 - $32.08 $1.27 Million - $1.9 Million	59,299 Added 58711.88%	59,400 $1.4 Million
Q1 2023 Apr 27, 2023	BUY	$21.42 - $32.08 $255,304 - $382,361	11,919 Added 25.1%	59,400 $1.4 Million

Q4 2022 Jan 26, 2023	BUY	$23.31 - $28.61 $154,545 - $189,684	6,630 Added 16.23%	47,481 $1.33 Million
Q3 2022 Oct 27, 2022	SELL	$23.4 - $34.25 $134,105 - $196,286	-5,731 Reduced 12.3%	40,851 $955,000
Q2 2022 Jul 25, 2022	BUY	$31.66 - $38.9 $1.47 Million - $1.81 Million	46,481 Added 46020.79%	46,582 $1.57 Million
Q4 2021 Jan 24, 2022	SELL	$28.67 - $37.13 $80,103 - $103,741	-2,794 Reduced 96.51%	101 $3,000
Q3 2021 Oct 22, 2021	SELL	$28.63 - $35.64 $2,863 - $3,564	-100 Reduced 3.34%	2,895 $94,000
Q2 2021 Jul 26, 2021	BUY	$28.45 - $38.0 $85,207 - $113,810	2,995 New	2,995 $90,000

Others Institutions Holding OGN

# of Institutions

786

Shares Held

190M

Call Options Held

2.46M

Put Options Held

2.27M

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $5.12B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account